{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:28:23Z","timestamp":1787599703848,"version":"build-2736575974"},"posted":{"date-parts":[[2026,1,21]]},"group-title":"In Review","reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,12]]},"abstract":"<title>Abstract<\/title>\n                <p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder that affects over 12 million people worldwide. A central pathological feature is the accumulation of aggregated alpha-synuclein (\u03b1S) in Lewy bodies and Lewy neurites. Engineered \u03b1S variants such as 3K (E35K\u2009+\u2009E46K\u2009+\u2009E61K) and KLK (KTKEGV\u2192KLKEGV in 6 repeats) have been shown to enhance membrane binding and aggregation propensity, contributing to cellular toxicity. To further investigate the impact of 3K and KLK on \u03b1S biology, we developed a sensitive assay in a human neuroblastoma model to assess expression levels and cytotoxicity. Relative to wild-type \u03b1S, the 3K mutant exhibited reduced steady-state expression and increased toxicity, consistent with prior reports. In contrast, the KLK mutant showed no marked change in protein expression but induced significantly higher toxicity, more than the 3K variant. These findings underscore the utility of our assay in dissecting disease-relevant mechanisms and highlight the potential of engineered \u03b1S variants to model pathogenic features of PD. This platform offers a versatile tool for evaluating therapeutic strategies targeting \u03b1S aggregation and toxicity in PD and related synucleinopathies.<\/p>","DOI":"10.21203\/rs.3.rs-8576084\/v1","type":"posted-content","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:07:27Z","timestamp":1769022447000},"source":"Crossref","is-referenced-by-count":0,"title":["Quantifying the Acute Toxicity of Alpha-Synuclein Membrane-Accumulation in a Cell-Based Assay"],"prefix":"10.21203","author":[{"given":"Baoyi","family":"Li","sequence":"first","affiliation":[{"name":"Wycombe Abbey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirah K.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital and Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren A.","family":"Levy","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendran","family":"Ramalingam","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital and Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Dettmer","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital and Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"6","key":"ref1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/insects16060583","article-title":"Tissue-Specific Fluorescent Protein Turnover in Free-Moving Flies","volume":"16","author":"Bell KS","year":"2025","unstructured":"Bell KS, Ko S, Ali S, Bognar B, Khmelkov M, Rau N, Peng OK, Eyuboglu M, Paine J, Tong A, Saria A, Agrawal S, Davies KJA, Tower J (2025) Tissue-Specific Fluorescent Protein Turnover in Free-Moving Flies. Insects 16(6):583. https:\/\/doi.org\/10.3390\/insects16060583","journal-title":"Insects"},{"issue":"6","key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor JT","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH (2013) The function of \u03b1-synuclein. Neuron 79(6). Article 6. https:\/\/doi.org\/10.1016\/j.neuron.2013.09.004","journal-title":"Neuron"},{"issue":"10291","key":"ref3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem BR","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"18","key":"ref4","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1093\/nar\/23.18.3656","article-title":"Picornavirus internal ribosome entry segments: Comparison of translation efficiency and the requirements for optimal internal initiation of translation in vitro","volume":"23","author":"Borman AM","year":"1995","unstructured":"Borman AM, Bailly J-L, Girard M, Kean KM (1995) Picornavirus internal ribosome entry segments: Comparison of translation efficiency and the requirements for optimal internal initiation of translation in vitro. Nucleic Acids Res 23(18):3656\u20133663. https:\/\/doi.org\/10.1093\/nar\/23.18.3656","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"ref5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi P","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14(3):176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"issue":"9440","key":"ref6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-synuclein locus duplication as a cause of familial Parkinson \u2019s disease","volume":"364","author":"Chartier-Harlin M-C","year":"2004","unstructured":"Chartier-Harlin M-C, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M (2004) \u03b1-synuclein locus duplication as a cause of familial Parkinson \u2019s disease. Lancet 364(9440):1167\u20131169","journal-title":"Lancet"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1743-422X-3-14","article-title":"Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI","volume":"3","author":"Chinnasamy D","year":"2006","unstructured":"Chinnasamy D, Milsom MD, Shaffer J, Neuenfeldt J, Shaaban AF, Margison GP, Fairbairn LJ, Chinnasamy N (2006) Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI. Virol J 3(1):14. https:\/\/doi.org\/10.1186\/1743-422X-3-14","journal-title":"Virol J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00623","author":"Dettmer U","year":"2018","unstructured":"Dettmer U (2018) Rationally Designed Variants of \u03b1-Synuclein Illuminate Its in vivo Structural Properties in Health and Disease. Frontiers in Neuroscience, 12. https:\/\/doi.org\/10.3389\/fnins.2018.00623"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1038\/ncomms8314","article-title":"Parkinson-causing \u03b1-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation","volume":"6","author":"Dettmer U","year":"2015","unstructured":"Dettmer U, Newman AJ, Soldner F, Luth ES, Kim NC, Saucken V, Sanderson VE, Jaenisch JB, Bartels R, T., Selkoe D (2015a) Parkinson-causing \u03b1-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun 6(1):7314","journal-title":"Nat Commun"},{"key":"ref10","author":"Dettmer U","year":"2015b","unstructured":"Dettmer U, Newman AJ, von Saucken VE, Bartels T, Selkoe D (2015b) KTKEGV repeat motifs are key mediators of normal \u03b1-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity. Proceedings of the National Academy of Sciences, 112(31), 9596\u20139601"},{"issue":"18","key":"ref11","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1093\/hmg\/ddx227","article-title":"Loss of native \u03b1-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells","volume":"26","author":"Dettmer U","year":"2017","unstructured":"Dettmer U, Ramalingam N, von Saucken VE, Kim T-E, Newman AJ, Terry-Kantor E, Nuber S, Ericsson M, Fanning S, Bartels T, Lindquist S, Levy OA, Selkoe D (2017) Loss of native \u03b1-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells. Hum Mol Genet 26(18):3466\u20133481. https:\/\/doi.org\/10.1093\/hmg\/ddx227","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"892138","DOI":"10.3389\/fbioe.2022.892138","article-title":"mCherry contains a fluorescent protein isoform that interferes with its reporter function","volume":"10","author":"Fages-Lartaud M","year":"2022","unstructured":"Fages-Lartaud M, Tietze L, Elie F, Lale R, Hohmann-Marriott MF (2022) mCherry contains a fluorescent protein isoform that interferes with its reporter function. Front Bioeng Biotechnol 10:892138","journal-title":"Front Bioeng Biotechnol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1604645113","author":"Flagmeier P","year":"2016","unstructured":"Flagmeier P, Meisl G, Vendruscolo M, Knowles TPJ, Dobson CM, Buell AK, Galvagnion C (2016) Mutations associated with familial Parkinson\u2019s disease alter the initiation and amplification steps of \u03b1-synuclein aggregation. Proceedings of the National Academy of Sciences, 113(37), 10328\u201310333. https:\/\/doi.org\/10.1073\/pnas.1604645113"},{"issue":"5","key":"ref14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"issue":"16","key":"ref15","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1093\/nar\/29.16.3327","article-title":"Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs","volume":"29","author":"Hennecke M","year":"2001","unstructured":"Hennecke M, Kwissa M, Metzger K, Oumard A, Kr\u00f6ger A, Schirmbeck R, Reimann J, Hauser H (2001) Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res 29(16):3327\u20133334. https:\/\/doi.org\/10.1093\/nar\/29.16.3327","journal-title":"Nucleic Acids Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1703420114","author":"\u00cd\u00f1igo-Marco I","year":"2017","unstructured":"\u00cd\u00f1igo-Marco I, Valencia M, Larrea L, Bugallo R, Mart\u00ednez-Goikoetxea M, Zuriguel I, Arrasate M (2017) E46K \u03b1-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation. Proceedings of the National Academy of Sciences, 114(39), E8274\u2013E8283. https:\/\/doi.org\/10.1073\/pnas.1703420114"},{"issue":"8","key":"ref17","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1128\/JVI.62.8.2636-2643.1988","article-title":"A segment of the 5\u2019 nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation","volume":"62","author":"Jang SK","year":"1988","unstructured":"Jang SK, Kr\u00e4usslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E (1988) A segment of the 5\u2019 nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62(8):2636\u20132643. https:\/\/doi.org\/10.1128\/JVI.62.8.2636-2643.1988","journal-title":"J Virol"},{"issue":"4","key":"ref18","doi-asserted-by":"publisher","first-page":"e18556","DOI":"10.1371\/journal.pone.0018556","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim JH","year":"2011","unstructured":"Kim JH, Lee S-R, Li L-H, Park H-J, Park J-H, Lee KY, Kim M-K, Shin BA, Choi S-Y (2011) High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS ONE 6(4):e18556. https:\/\/doi.org\/10.1371\/journal.pone.0018556","journal-title":"PLoS ONE"},{"issue":"4","key":"ref19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome","volume":"73","author":"Lesage S","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, Bousset L, Honor\u00e9 A, Rozas N, Pieri L, Madiona K, D\u00fcrr A, Melki R, Verny C, Brice A, Group (2013) G51D \u03b1-synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome. Ann Neurol 73(4):459\u2013471 for the F. P. D. G. S. https:\/\/doi.org\/10.1002\/ana.23894","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"106646","DOI":"10.1016\/j.nbd.2024.106646","article-title":"Interactions of alpha-synuclein with membranes in Parkinson\u2019s disease: Mechanisms and therapeutic strategies","volume":"201","author":"Li B","year":"2024","unstructured":"Li B, Dettmer U (2024) Interactions of alpha-synuclein with membranes in Parkinson\u2019s disease: Mechanisms and therapeutic strategies. Neurobiol Dis 201:106646. https:\/\/doi.org\/10.1016\/j.nbd.2024.106646","journal-title":"Neurobiol Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.23.678012","author":"Li B","year":"2025","unstructured":"Li B, Levy OA, Ramalingam N, Dettmer U (2025) A Dual Assay to Compare Protein Levels and Toxicity of Alpha-Synuclein Variants: Acute Expression of Wild-Type versus S129A (p. 2025.09.23.678012). bioRxiv. https:\/\/doi.org\/10.1101\/2025.09.23.678012"},{"issue":"4","key":"ref22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/mthe.2000.0050","article-title":"IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector","volume":"1","author":"Mizuguchi H","year":"2000","unstructured":"Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T (2000) IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Therapy: J Am Soc Gene Therapy 1(4):376\u2013382. https:\/\/doi.org\/10.1006\/mthe.2000.0050","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"9","key":"ref23","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology","volume":"35","author":"Pasanen P","year":"2014","unstructured":"Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, Tienari PJ, P\u00f6yh\u00f6nen M, Paetau A (2014) A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging 35(9):2180. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.024","journal-title":"Neurobiol Aging"},{"issue":"6180","key":"ref24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/334320a0","article-title":"Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA","volume":"334","author":"Pelletier J","year":"1988","unstructured":"Pelletier J, Sonenberg N (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334(6180):320\u2013325. https:\/\/doi.org\/10.1038\/334320a0","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100271","author":"Ramalingam N","year":"2021","unstructured":"Ramalingam N, Dettmer U (2021) Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons. Journal of Biological Chemistry, 296. https:\/\/doi.org\/10.1016\/j.jbc.2021.100271"},{"issue":"1","key":"ref26","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1038\/s41598-017-02459-9","article-title":"Using bicistronic constructs to evaluate the chaperone activities of heat shock proteins in cells","volume":"7","author":"San Gil R","year":"2017","unstructured":"San Gil R, Berg T, Ecroyd H (2017) Using bicistronic constructs to evaluate the chaperone activities of heat shock proteins in cells. Sci Rep 7(1):2387. https:\/\/doi.org\/10.1038\/s41598-017-02459-9","journal-title":"Sci Rep"},{"issue":"12","key":"ref27","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nbt1037","article-title":"Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. Red fluorescent protein","volume":"22","author":"Shaner NC","year":"2004","unstructured":"Shaner NC, Campbell RE, Steinbach PA, Giepmans BNG, Palmer AE, Tsien RY (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. Red fluorescent protein. Nat Biotechnol 22(12):1567\u20131572. https:\/\/doi.org\/10.1038\/nbt1037","journal-title":"Nat Biotechnol"},{"issue":"5646","key":"ref28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein Locus Triplication Causes Parkinson\u2019s Disease","volume":"302","author":"Singleton AB","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Gwinn-Hardy K (2003) \u03b1-Synuclein Locus Triplication Causes Parkinson\u2019s Disease. Science 302(5646):841\u2013841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science"},{"issue":"6645","key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini MG","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645). Article 6645. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"ref30","author":"Su D","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JS, Zhang J, Yan R, Zheng X (2025) Projections for prevalence of Parkinson \u2019s disease and its driving factors in 195 countries and territories to 2050: Modelling study of Global Burden of Disease Study 2021. Bmj, 388. Tenreiro, S"},{"issue":"5","key":"ref31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nbt957","article-title":"Correction of multi-gene deficiency in vivo using a single self-cleaving 2A peptide-based retroviral vector","volume":"22","author":"Szymczak AL","year":"2004","unstructured":"Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, Vignali DAA (2004) Correction of multi-gene deficiency in vivo using a single self-cleaving 2A peptide-based retroviral vector. Nat Biotechnol 22(5):589\u2013594. https:\/\/doi.org\/10.1038\/nbt957","journal-title":"Nat Biotechnol"},{"issue":"1","key":"ref32","doi-asserted-by":"publisher","first-page":"16696","DOI":"10.1038\/srep16696","article-title":"Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson\u2019s disease genetically related mutants","volume":"5","author":"Tosatto L","year":"2015","unstructured":"Tosatto L, Horrocks MH, Dear AJ, Knowles TPJ, Dalla Serra M, Cremades N, Dobson CM, Klenerman D (2015) Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson\u2019s disease genetically related mutants. Sci Rep 5(1):16696. https:\/\/doi.org\/10.1038\/srep16696","journal-title":"Sci Rep"},{"issue":"5","key":"ref33","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.jmb.2006.12.044","article-title":"Relationships between the Sequence of \u03b1-Synuclein and its Membrane Affinity, Fibrillization Propensity, and Yeast Toxicity","volume":"366","author":"Volles MJ","year":"2007","unstructured":"Volles MJ, Lansbury PT (2007) Relationships between the Sequence of \u03b1-Synuclein and its Membrane Affinity, Fibrillization Propensity, and Yeast Toxicity. J Mol Biol 366(5):1510\u20131522. https:\/\/doi.org\/10.1016\/j.jmb.2006.12.044","journal-title":"J Mol Biol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"104543","DOI":"10.1016\/j.nbd.2019.104543","article-title":"Dynamic behaviors of \u03b1-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration","volume":"132","author":"Yeboah F","year":"2019","unstructured":"Yeboah F, Kim T-E, Bill A, Dettmer U (2019) Dynamic behaviors of \u03b1-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration. Neurobiol Dis 132:104543. https:\/\/doi.org\/10.1016\/j.nbd.2019.104543","journal-title":"Neurobiol Dis"},{"issue":"2","key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz JJ","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atar\u00e9s B, Llorens V, Gomez Tortosa E, del Ser T, Mu\u00f1oz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2) Article 2. https:\/\/doi.org\/10.1002\/ana.10795","journal-title":"Ann Neurol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8576084\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8576084\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:17:42Z","timestamp":1787599062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8576084\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":35,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8576084\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s12031-026-02578-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,1,21]]},"subtype":"preprint"}}